Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Abhay Chauhan PhD

Abhay Chauhan PhD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: School of Pharmacy Administration
Division: Administration
Program: Program Development

Publications (18)

  • An innovative in situ method of creating hybrid dendrimer nano-assembly: An efficient next generation dendritic platform for drug delivery. (Singh MK, Kuncha M, Nayak VL, Sarma AVS, Kumar MJM, Chauhan AS, Sistla R) Nanomedicine 2019 10;21:102043 PMID: 31247312 SCOPUS ID: 2-s2.0-85068969431 06/28/2019       15 Citations
  • Dendrimers for Drug Delivery. (Chauhan AS) Molecules 2018 Apr 18;23(4) PMID: 29670005 PMCID: PMC6017392 SCOPUS ID: 2-s2.0-85045612173 04/20/2018       113 Citations
  • Development of a Topical Resveratrol Formulation for Commercial Applications Using Dendrimer Nanotechnology. (Pentek T, Newenhouse E, O'Brien B, Chauhan AS) Molecules 2017 Jan 14;22(1) PMID: 28098828 PMCID: PMC6155877 SCOPUS ID: 2-s2.0-85009454713 01/19/2017       41 Citations
  • Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide. (Singh MK, Pooja D, Kulhari H, Jain SK, Sistla R, Chauhan AS) Eur J Pharm Sci 2017 Jan 01;96:84-92 PMID: 27614111 SCOPUS ID: 2-s2.0-84987906214 10/28/2016       18 Citations
  • siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector. (Tekade RK, Maheshwari RG, Sharma PA, Tekade M, Chauhan AS) Curr Pharm Des 2015;21(31):4614-36 PMID: 26486147 SCOPUS ID: 2-s2.0-84946718579 10/22/2015       51 Citations
  • Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer. (Katare YK, Daya RP, Sookram Gray C, Luckham RE, Bhandari J, Chauhan AS, Mishra RK) Mol Pharm 2015 Sep 08;12(9):3380-8 PMID: 26226403 SCOPUS ID: 2-s2.0-84941360130 08/01/2015       56 Citations
  • Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol. (Chauhan AS) Ann N Y Acad Sci 2015 Aug;1348(1):134-40 PMID: 26173478 SCOPUS ID: 2-s2.0-85006371505 07/16/2015       38 Citations
  • Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics. (Tekade RK, Tekade M, Kumar M, Chauhan AS) Pharm Res 2015 Mar;32(3):910-28 PMID: 25205461 SCOPUS ID: 2-s2.0-84922998546 09/11/2014       60 Citations
  • Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation. (Kulhari H, Pooja D, Singh MK, Chauhan AS) Drug Dev Ind Pharm 2015 Feb;41(2):232-8 PMID: 24237325 SCOPUS ID: 2-s2.0-84921917836 11/19/2013       37 Citations
  • Pharmacokinetic and pharmacodynamic studies of poly(amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia. (Kulhari H, Kulhari DP, Prajapati SK, Chauhan AS) Mol Pharm 2013 Jul 01;10(7):2528-33 PMID: 23692066 SCOPUS ID: 2-s2.0-84879731719 05/23/2013       32 Citations
  • Development and optimization of thiolated dendrimer as a viable mucoadhesive excipient for the controlled drug delivery: an acyclovir model formulation. (Yandrapu SK, Kanujia P, Chalasani KB, Mangamoori L, Kolapalli RV, Chauhan A) Nanomedicine 2013 May;9(4):514-22 PMID: 23117047 SCOPUS ID: 2-s2.0-84876740494 11/03/2012       32 Citations
  • Performance evaluation of PAMAM dendrimer based simvastatin formulations. (Kulhari H, Pooja D, Prajapati SK, Chauhan AS) Int J Pharm 2011 Feb 28;405(1-2):203-9 PMID: 21145960 SCOPUS ID: 2-s2.0-79151485330 12/15/2010       73 Citations
  • Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. (Chauhan AS, Diwan PV, Jain NK, Tomalia DA) Biomacromolecules 2009 May 11;10(5):1195-202 PMID: 19348417 SCOPUS ID: 2-s2.0-66149083636 04/08/2009       147 Citations
  • Dendrimers for enhanced drug solubilization. (Svenson S, Chauhan AS) Nanomedicine (Lond) 2008 Oct;3(5):679-702 PMID: 18817470 SCOPUS ID: 2-s2.0-55949114221 09/27/2008       114 Citations
  • Controlled systemic delivery of indomethacin using membrane-moderated, cream formulation-based transdermal devices. (Rao PR, Chalasani KB, Chauhan AS, Jain AK, Diwan PV, Ram MK) Drug Deliv 2006 May-Jun;13(3):207-13 PMID: 16556573 SCOPUS ID: 2-s2.0-33645285564 03/25/2006       2 Citations
  • Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. (Asthana A, Chauhan AS, Diwan PV, Jain NK) AAPS PharmSciTech 2005 Oct 27;6(3):E536-42 PMID: 16354015 PMCID: PMC2750401 SCOPUS ID: 2-s2.0-27744579521 12/16/2005       166 Citations
  • Solubility enhancement of indomethacin with poly(amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats. (Chauhan AS, Jain NK, Diwan PV, Khopade AJ) J Drug Target 2004;12(9-10):575-83 PMID: 15621683 SCOPUS ID: 2-s2.0-11944272030 12/29/2004       143 Citations
  • Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. (Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, Diwan PV) J Control Release 2003 Jul 31;90(3):335-43 PMID: 12880700 SCOPUS ID: 2-s2.0-0037897487 07/26/2003       296 Citations
  • Last update: 01/01/2021